EVENTS | VIEW CALENDAR
Stem cell research survey initiated by ddn and Mizuho
Concurrent with our summer feature series on stem cell research, Drug Discovery News (ddn), in partnership with the healthcare research team at investment bank Mizuho Securities USA, is conducting a reader survey on current stem cell trends and usage.
Whether you work at the bench or for an academic institution—or anywhere in between—we are interested in finding out about your participation in and views on the stem cell market.
The survey contains 20 questions and takes four to five minutes to complete. To participate, please click on the link below:
All information will remain confidential, and only aggregate results will be published.
If you are interested in receiving a copy of the survey results, please indicate at the end of the survey.